Effective January 24, 2022, the FDA updated the Emergency Use Authorization (EUA) fact sheets for two COVID-19 monoclonal antibody treatments: bamlanivimab plus etesevimab (Eli Lilly) and casirivimab plus imdevimab (Regeneron, also known as REGEN-COV). Neither of these treatments are authorized for use anywhere in the U.S. due to their ineffectiveness against the dominant Omicron variant. Sites are directed to immediately stop administering these therapeutics as they do not retain EUA.

Ph: (443) 281-9157

Fax: (410) 582-8728

801 Landmark Dr.
Glen Burnie, MD 21061
Contact Us

Mon-Fri: 8:30AM-6:30PM

Sat: 9:00AM-2:00PM

Dispill Packaging

Simple and Safe

Why waste time sorting or worrying about medication? This innovative multi-dose packaging system makes everything simpler. Sorted and packaged by our pharmacist, each dose is personalized just for you.

And, they’re clearly labeled by date and time of day, giving you the comfort of knowing you took the right medication at the right time.
No more guesswork, and no more bottles or pillboxes.

  • Color-coded by time of day
  • Detachable and portable
  • Convenient packaging
  • Filled by our pharmacist